Metzger Michael A 4
4 · Syndax Pharmaceuticals Inc · Filed Jul 18, 2025
Insider Transaction Report
Form 4
Metzger Michael A
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-07-16$9.29/sh−7,534$69,953→ 298,661 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.